Accelrys Biological Registration: Mastering Biological R&D at Its Roots
White Paper Nov 25, 2010
This IDC Health Insights Perspective highlights a new product solution that promises to more effectively register, track, and manage promising biologics, resulting in more efficient biological product development and more systematic intellectual property management and protection. Accelrys' new Biological Registration system is the next step in the extension of its Accord chemical registration capabilities to biological entity registration. With the expanded product portfolio from its proposed merger with Symyx Technologies, Accelrys becomes the dominant industry leader for chemical and biological registration solutions, taking chemical and biologic entity management to a new level.
Related White Papers
Using Micro Flow Imaging (MFI) to Measure Protein AggregationWhite Paper
Download this free white paper from Protein Simple to learn about the differences between MFI and how MFI provides crucial information about your protein therapeutic.READ MORE
Meeting Modern Data Integrity and Compliance RequirementsWhite Paper
The accuracy and completeness of data is crucial for safe product development and to prevent serious implications regarding human health.READ MORE
Big Data Lipidomics for Lipid Biomarker Identification and Drug DiscoveryWhite Paper
Data analysis process aiming at the identification of lipid biomarkers and the
evaluations of their performance.